Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …

Background Studies have reported a significant association between non-alcoholic fatty liver
disease (NAFLD) and increased incidence of cardiovascular disease (CVD). However, the …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both
manifestations of end-organ damage of the metabolic syndrome. Through multiple …

Recognition of the link between non‐alcoholic fatty liver disease (NAFLD) and
cardiovascular disease (CVD) has boosted research in this area. The main objective of this …

Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to cardiovascular
disease (CVD). The aim of this study is to assess whether and to what extent the excess risk …

Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) is associated with an increased
prevalence of chronic kidney disease (CKD) and retinopathy in patients with type 2 diabetes …

Fatty liver, which frequently coexists with necro-inflammatory and fibrotic changes, may
occur in the setting of nonalcoholic fatty liver disease (NAFLD) and chronic infections due to …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide. It is strongly associated with obesity, type 2 diabetes (T2DM), and other …

Background & Aims There have been many studies of the effects of non-alcoholic fatty liver
disease (NAFLD) and the risk of cardiovascular disease (CVD), but these have produced …

Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …